8 completed. 8 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 8 |
| Phase 1 | 4 | Completed 4 |
Follow Necrotizing Enterocolitis: new trials by email Literature Review of Necrotizing Enterocolitis trials Research Report on Necrotizing Enterocolitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RIC-NEC Randomized Controlled Trial Remote ischemic conditioning (RIC) + Standard of Care for NEC, Standard of Care for NEC - Necrotizing Enterocolitis | Phase 2 | Completed | The Hospital for Sick Children | 86 | 2023-02-09 | 2026-11-03 |
| Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis Melatonin 6 MG, Breast Milk - Necrotizing Enterocolitis | Phase 1 / Phase 2 | Completed | Ilocos Training and Regional Medical Center | 100 | 2021-03-01 | 2024-06-20 |
| IBP-9414 for the Prevention of Necrotizing Enterocolitis IBP-9414, Placebo - Necrotizing Enterocolitis | Phase 2 | Completed | Infant Bacterial Therapeutics | 120 | 2016-05-27 | 2017-12-29 |
| Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus pharmacologic treatment of the PDA, no pharmacologic treatment of the PDA, NSAID - Patent Ductus Arteriosus, Surgery | Phase 2 | Completed | University of California, San Francisco | 202 | 2013-12-01 | 2018-11-30 |
| Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm Neonates Docosahexaenoic acid (DHA), Placebo - Necrotizing Enterocolitis | Phase 1 / Phase 2 | Completed | Coordinación de Investigación en Salud, Mexico | 225 | 2012-10-01 | 2021-03-24 |
| Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial recombinant human G-CSF, and rhEPO, rh G-CSF, rh EPO - Feeding Intolerance, Necrotizing Enterocolitis | Phase 1 / Phase 2 | Completed | Ain Shams University | 93 | 2010-01-01 | 2011-09-27 |
| Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections meropenem - Necrotizing Enterocolitis, Intra-abdominal Infection | Phase 1 / Phase 2 | Completed | The Emmes Company, LLC | 200 | 2008-06-01 | 2023-04-25 |
| Lactulose Supplementation in Premature Infants Lactulose, Dextrose - Necrotizing Enterocolitis, Sepsis | Phase 2 | Completed | Bnai Zion Medical Center | 28 | 2005-02-01 | 2008-02-15 |
Enterocolitis, Necrotizing (8) · Premature Birth (2) · Ductus Arteriosus, Patent (1) · Intestinal Perforation (1) · Intraabdominal Infections (1) · Sepsis (1)
Digestive System Diseases (8) · Enterocolitis (8) · Gastroenteritis (8) · Gastrointestinal Diseases (8) · Intestinal Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (2) · Infections (2) · Obstetric Labor Complications (2) · Obstetric Labor, Premature (2) · Pregnancy Complications (2) · Urogenital Diseases (2) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Anti-Inflammatory Agents, Non-Steroidal (1) · Docosahexaenoic Acids (1) · Fatty Acids, Omega-3 (1) · Glucose (1) · Lactulose (1) · Melatonin (1) · Meropenem (1) · Milk, Human (1) · Standard of Care (1) · Sunflower Oil (1)
Ain Shams University (1) · Bnai Zion Medical Center (1) · Coordinación de Investigación en Salud, Mexico (1) · Ilocos Training and Regional Medical Center (1) · Infant Bacterial Therapeutics (1) · The Emmes Company, LLC (1) · The Hospital for Sick Children (1) · University of California, San Francisco (1)
United States (4) · Canada (1) · Israel (1) · Mexico (1) · Philippines (1) · Sweden (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Agostino Pierro, OBE, MD (1) · Arieh Riskin, MD (1) · Daisy Evangeline C Garcia, MD (1) · Danny Benjamin, MD, PhD, MPH (1) · Josef Neu, MD (1) · Mariela Bernabe-Garcia, PhD (1) · Navid P Roodaki, MD (1) · Ron Shaoul, MD (1) · Ronald Clyman, MD (1)
PMID 22955430, PMID 25155966, PMID 30340932, PMID 30850756, PMID 31255386, PMID 33671220